Cancer Center AssociatesMar 8, 20212 minFDA Approves Libtayo for NSCLC With High PD-L1 ExpressionLibtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
Dr. Amanullah Khan MDMar 8, 20211 minTAGRISSO- New Indications for Non Small Cell Lung Cancer!New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
